Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
105M
-
Number of holders
-
1149
-
Total 13F shares, excl. options
-
89.9M
-
Shares change
-
-765K
-
Total reported value, excl. options
-
$74B
-
Value change
-
-$573M
-
Put/Call ratio
-
1.09
-
Number of buys
-
481
-
Number of sells
-
-513
-
Price
-
$822.96
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q3 2023
1,315 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q3 2023.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 1,149 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 89.9M shares
of 105M outstanding shares and own 85.66% of the company stock.
Largest 10 shareholders include FMR LLC (9.84M shares), BlackRock Inc. (8.88M shares), VANGUARD GROUP INC (8.8M shares), JPMORGAN CHASE & CO (7.39M shares), Capital World Investors (5.11M shares), STATE STREET CORP (4.83M shares), Capital International Investors (2.97M shares), Dodge & Cox (2.37M shares), GEODE CAPITAL MANAGEMENT, LLC (2.32M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (2.22M shares).
This table shows the top 1149 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.